Lisata Therapeuti…
USUSDLisata Therapeutics Inc. (LSE:0HS8) — Biotechnology: Pharmaceutical Preparations. Numero di borse in cui sono quotate le azioni della società: 2. In questa pagina: prezzo e grafico, dividendi, principali azionisti e cronologia del numero di azioni.
Informazioni sull'azienda
- Sito web
- caladrius.com
- Settore
- Health Care · Biotechnology: Pharmaceutical Preparations
- Sede centrale
- New York City, United States
- Dipendenti
- 21
- Fondata
- 2006
- Azioni in circolazione
- 9.01 Mln al 2026-08-06
- Flottante
- 6.65 Mln
- Capitalizzazione di mercato
- 15.56 Mln USD
- Insider
- 22.26%
- Investitori istituzionali
- 13.41%
- Settore (SIC)
- Pharmaceutical Preparations
- ISIN
- US1280583022
- LEI
- 5493002287F62M3EGQ04
Descrizione
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with range of anti-cancer regimens. Lisata Therapeutics, Inc. was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. in September 2022. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.
Dividendi
Nessun pagamento di dividendi trovato (controllato 07.10.2026). Probabilmente la società non distribuisce dividendi.
Notizie di questa settimana
Ancora nessuna notizia dal sito della società.
Principali azionisti
| Detentore | Quota | Azioni | Data del rapporto |
|---|---|---|---|
| Deeter Investments Llp | 4.04% | 364 479 | 2026-03-31 |
| MAZZO DAVID J (Officer a… | ≈3.46% | 311 890 | 2026-01-09 |
| Vanguard Capital Managem… | 3.09% | 278 837 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.12% | 191 371 | 2026-06-30 |
| Yakira Capital Managemen… | 1.54% | 138 561 | 2026-06-30 |
| CSS LLC | 1.23% | 110 422 | 2026-06-30 |
| AZAB MOHAMMAD (Director) | ≈1.16% | 104 925 | 2026-01-09 |
| KLOSK STEVEN MARK (Direc… | ≈1.06% | 95 815 | 2026-01-09 |
| BROWN GREGORY B (Directo… | ≈1.06% | 95 659 | 2026-01-09 |
| FLOWERS CYNTHIA LOUISE (… | ≈1.06% | 95 446 | 2026-01-09 |
| BUCK KRISTEN K (Officer) | ≈1.04% | 93 462 | 2026-01-09 |
| HENSON HEIDI (Director) | ≈0.95% | 85 725 | 2026-01-09 |
| Deltec Asset Management… | 0.92% | 83 197 | 2026-06-30 |
| Rangeley Capital, LLC | 0.9% | 81 000 | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 0.89% | 80 444 | 2026-06-30 |
| Geode Capital Management… | 0.81% | 72 632 | 2026-06-30 |
| Virtu Financial LLC | 0.65% | 58 782 | 2026-06-30 |
| Blackrock Inc. | 0.61% | 54 857 | 2026-06-30 |
| Vanguard Fiduciary Trust… | 0.54% | 48 964 | 2026-06-30 |
| Fidelity Concord Street… | 0.42% | 38 275 | 2026-07-31 |
| IMAM TARIQ (General Coun… | ≈0.4% | 36 078 | 2026-01-09 |
| NISCO JAMES (Officer) | ≈0.36% | 32 311 | 2026-01-09 |
| Fidelity Concord Street… | 0.12% | 10 373 | 2026-07-31 |
| VANGUARD VALLEY FORGE FU… | 0.08% | 7 022 | 2026-06-30 |
| Fidelity Concord Street… | 0.05% | 4 427 | 2026-07-31 |
| Fidelity Concord Street… | 0.05% | 4 379 | 2026-07-31 |
| DFA INVESTMENT DIMENSION… | 0.02% | 2 185 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0% | 100 | 2026-07-31 |
| Dimensional ETF Trust-Di… | 0% | 8 | 2026-07-31 |
